← Leaderboards

Adil E. Bharucha

Mayo Clinic Coll Of Medicine, Rochester

Google Scholar ↗PubMed ↗ORCID ↗

$16,932,684

Attributed

$26,213,164

Total exposure

20

Grants

7

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.3M · FY2005–25

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$30,187,992 · 21

By mechanism

U01$11,413,736 · 2

R01$9,095,175 · 4

P01$8,890,198 · 4

U34$711,433 · 1

M01$77,450 · 10

Top collaborators

Most similar at Mayo Clinic Coll Of Medicine, Rochester

Same institution · by research overlap

Joseph H. Szurszewski$10,328,408

Others in their field

Top investigators on “Symptoms”

Randall J Bateman · Washington University$155,860,406
Judith S Hochman · New York University School Of Medicine$111,581,511
Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$98,224,091
Eric Martin McDade · Washington University$96,219,353
Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Monica M Bertagnolli · Strang Cancer Prevention Center$85,994,687

Research focus

SymptomsFunctional DisorderMagnetic Resonance ImagingDesignClinical ResearchAffectFecal IncontinenceHuman SubjectConstipationDiabetes MellitusBaseInnovationChronicRectalAnusSphincter Ani Muscle StructurePressureEnteralBiofeedbackEpidemiologyPathway InteractionsPelvic Floor StructureMultidisciplinaryRandomized

Grant awards (71)

Mayo Clinic Consortium for Gut Brain Communication in Parkinson's Disease$726,298

U01 · FY2025 · DK · contact PI

Single-cell epigenomics and transcriptomics of diabetic gastroparesis in humans$397,500

R01 · FY2025 · DK · contact PI

Mayo Clinic Consortium for Gut Brain Communication in Parkinson (Administrative Supplement)$215,000

U01 · FY2025 · DK · contact PI

Mayo Clinic Consortium for Gut Brain Communication in Parkinson's Disease$484,200

U01 · FY2024 · DK · contact PI

Single-cell epigenomics and transcriptomics of diabetic gastroparesis in humans$381,600

R01 · FY2024 · DK · contact PI

Fecal Incontinence Treatment Study (FIT Study)$1,377,218

U01 · FY2023 · DK · contact PI

Single-cell epigenomics and transcriptomics of diabetic gastroparesis in humans$397,500

R01 · FY2023 · DK · contact PI

Pathophysiology of Anorectal Disorders$386,593

R01 · FY2023 · DK · contact PI

Fecal Incontinence Treatment Study (FIT Study)$1,319,046

U01 · FY2022 · DK

Single-cell epigenomics and transcriptomics of diabetic gastroparesis in humans$397,500

R01 · FY2022 · DK · contact PI

Pathophysiology of Anorectal Disorders$386,593

R01 · FY2022 · DK · contact PI

Single-cell epigenomics and transcriptomics of diabetic gastroparesis in humans$397,500

R01 · FY2021 · DK · contact PI

Pathophysiology of Anorectal Disorders$386,593

R01 · FY2021 · DK · contact PI

Fecal Incontinence Treatment Study (FIT Study)$2,400,000

U01 · FY2020 · DK

Pathophysiology of Anorectal Disorders$386,593

R01 · FY2020 · DK · contact PI

Fecal Incontinence Treatment Study (FIT Study)$2,400,000

U01 · FY2019 · DK

Pathobiology of the Enteric System$1,987,414

P01 · FY2019 · DK

Neurohumoral Regulation in Diabetic Enteropathy$492,900

P01 · FY2019 · DK · contact PI

Pathophysiology of Anorectal Disorders$407,255

R01 · FY2019 · DK · contact PI

Fecal Incontinence Treatment Study (FIT Study)$2,491,974

U01 · FY2018 · DK

Pathobiology of the Enteric System$1,987,414

P01 · FY2018 · DK

Neurohumoral Regulation in Diabetic Enteropathy$492,900

P01 · FY2018 · DK · contact PI

Pathophysiology of Anorectal Disorders$345,825

R01 · FY2018 · DK · contact PI

Neurohumoral Regulation in Diabetic Enteropathy$492,900

P01 · FY2017 · DK · contact PI

Pathophysiology of Anorectal Disorders$345,825

R01 · FY2017 · DK · contact PI

Comparative Effectiveness of Biofeedback, Sacral Nerve Stimulation, and Injectable Bulking Agents for Treatment of Fecal Incontinence$326,318

U34 · FY2017 · DK

Neurohumoral Regulation in Diabetic Enteropathy$492,900

P01 · FY2016 · DK · contact PI

Comparative Effectiveness of Biofeedback, Sacral Nerve Stimulation, and Injectable Bulking Agents for Treatment of Fecal Incontinence$385,115

U34 · FY2016 · DK

Pathophysiology of Anorectal Disorders$345,825

R01 · FY2016 · DK · contact PI

Neurohumoral Regulation in Diabetic Enteropathy$492,900

P01 · FY2015 · DK · contact PI

Pathophysiology of Anorectal Disorders$345,825

R01 · FY2015 · DK · contact PI

Neurohumoral Regulation in Diabetic Enteropathy$424,958

P01 · FY2014 · DK · contact PI

Pathophysiology of Anorectal Disorders$345,825

R01 · FY2014 · DK · contact PI

Neurohumoral Regulation in Diabetic Enteropathy$410,155

P01 · FY2013 · DK · contact PI

Pathophysiology of Anorectal Disorders$314,697

R01 · FY2011 · DK · contact PI

Pathophysiology of Anorectal Disorders$317,877

R01 · FY2010 · DK · contact PI

Pathophysiology of Anorectal Disorders$321,088

R01 · FY2009 · DK · contact PI

Neurohumoral Regulation in Diabetic Enteropathy$333,760

P01 · FY2008 · DK · contact PI

Pathophysiology of Anorectal Disorders$321,088

R01 · FY2008 · DK · contact PI

Neurohumoral Regulation in Diabetic Enteropathy$308,975

P01 · FY2007 · DK · contact PI

Neurohumoral Regulation in Diabetic Enteropathy$316,344

P01 · FY2006 · DK · contact PI

Neurohumoral Regulation in Diabetic Enteropathy$320,258

P01 · FY2005 · DK

Epidemiology and Mechanisms of Fecal Incontinence$290,464

R01 · FY2005 · HD

SORBITOL AND COLONIC TRANSIT$24,642

M01 · FY2005 · RR

EPIDEMIOLOGY AND MECHANISMS OF FECAL INCONTINENCE$21,088

M01 · FY2005 · RR

BIOMECHANICAL PROPERTIES OF THE HUMAN COLON$4,265

M01 · FY2005 · RR

EFFECT OF HYSTERECTOMY ON ANORECTAL SENSORI-MOTOR FUNCTIONS - A PILOT STUDY$2,369

M01 · FY2005 · RR

ASSESSMENT OF RECTAL EVALUATION AND INWARD TRACTION IN HUMANS$2,132

M01 · FY2005 · RR

ANORECTAL MANIFESTATIONS OF FEMALE PELVIC FLOOR DISORDERS$474

M01 · FY2005 · RR

Neurohumoral Regulation in Diabetic Enteropathy$336,420

P01 · FY2004 · DK

Epidemiology and Mechanisms of Fecal Incontinence$289,791

R01 · FY2004 · HD

Sorbitol and Colonic Transit$7,879

M01 · FY2004 · RR

Biomechanical Properties of the Human Colon$6,257

M01 · FY2004 · RR

Anorectal Manifestations of Female Pelvic Floor Disorders$3,245

M01 · FY2004 · RR

Colonic Mucosal Gene Expression Profile in IBS$3,245

M01 · FY2004 · RR

Assessment of Rectal Evaluation and Inward Traction$1,854

M01 · FY2004 · RR

Epidemiology and Mechanisms of Fecal Incontinence$290,733

R01 · FY2003 · HD

Epidemiology and Mechanisms of Fecal Incontinence$319,676

R01 · FY2002 · HD

ANORECTAL MANIFESTATIONS OF FEMALE PELVIC FLOOR DISORDER$214,221

R01 · FY2002 · HD

PYRIDOSTIGMINE FOR CONSTIPATION IN PATIENTS W/ AN AUTONOMIC NEUROPATHY$0

M01 · FY2002 · RR

BIOMECHANICAL PROPERITIES OF THE HUMAN COLON$0

M01 · FY2002 · RR

ASSESSMENT OF COLONIC PRESSURE VOLUME RELATIONSHIPS IN HEALTHY VOLUNTEERS$0

M01 · FY2002 · RR

Epidemiology and Mechanisms of Fecal Incontinence$332,475

R01 · FY2001 · HD

ANORECTAL MANIFESTATIONS OF FEMALE PELVIC FLOOR DISORDER$214,072

R01 · FY2001 · HD

ASSESSMENT OF COLONIC PRESSURE VOLUME RELATIONSHIPS IN HEALTHY VOLUNTEERS$0

M01 · FY2001 · RR

BIOMECHANICAL PROPERITIES OF THE HUMAN COLON$0

M01 · FY2001 · RR

PYRIDOSTIGMINE FOR CONSTIPATION IN PATIENTS W/ AN AUTONOMIC NEUROPATHY$0

M01 · FY2001 · RR

ANORECTAL MANIFESTATIONS OF FEMALE PELVIC FLOOR DISORDER$214,641

R01 · FY2000 · HD

PYRIDOSTIGMINE FOR CONSTIPATION IN PATIENTS W/ AN AUTONOMIC NEUROPATHY$0

M01 · FY2000 · RR

BIOMECHANICAL PROPERITIES OF THE HUMAN COLON$0

M01 · FY2000 · RR

ASSESSMENT OF COLONIC PRESSURE VOLUME RELATIONSHIPS IN HEALTHY VOLUNTEERS$0

M01 · FY2000 · RR